lessthanhalf
Explorer
I came across this study and found it worth sharing
Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00043-X/fulltext
According to it, individuals who shed pounds while on GLP's may, over the long haul, put back only 75% of what they had lost. That is a curious finding, and in the end it amounts to roughly a 5% weight reduction, which beats nothing at all. Still, my sense now is that a 20-30% loss is genuinely achievable if someone uses tirzepatide or retatrutide and remains on treatment. Perhaps even greater results could come from higher doses or from more experimental combinations.
Looking at the weight regain curve, it appears to flatten out eventually. Finding out the reason, and identifying what might be altered over the long term, would be a fascinating line of inquiry. The explanation offered in the articles, that food choices improve, does not strike me as convincing.
Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00043-X/fulltext
According to it, individuals who shed pounds while on GLP's may, over the long haul, put back only 75% of what they had lost. That is a curious finding, and in the end it amounts to roughly a 5% weight reduction, which beats nothing at all. Still, my sense now is that a 20-30% loss is genuinely achievable if someone uses tirzepatide or retatrutide and remains on treatment. Perhaps even greater results could come from higher doses or from more experimental combinations.
Looking at the weight regain curve, it appears to flatten out eventually. Finding out the reason, and identifying what might be altered over the long term, would be a fascinating line of inquiry. The explanation offered in the articles, that food choices improve, does not strike me as convincing.